Literature DB >> 25089552

Utility and Reproducibility of the International Federation for Cervical Pathology and Colposcopy Classification of Transformation Zones in Daily Practice: A Multicenter Study of the German Colposcopy Network.

Alexander Luyten1, Nina Buttmann-Schweiger, Ingke Hagemann, Sarah Scherbring, Gerd Boehmer, Friederike Gieseking, Linn Woelber, Frank Glasenapp, Monika Hampl, Christina Kuehler-Obbarius, Marcus van den Bergh, Karl Ulrich Petry.   

Abstract

OBJECTIVE: To compare the distribution of International Federation for Cervical Pathology and Colposcopy (IFCPC) transformation zone (TZ) types among women in different age groups referred to 8 colposcopy clinics.
MATERIALS AND METHODS: Between February 2012 and February 2013, we prospectively collected individual patient data from 8 clinics within the German Colposcopy Network (G-CONE). Data were analyzed using ODSdysplasie, software designed to allow continuous quality assessment in colposcopy clinics. The distribution of IFCPC-classified TZ was compared between different centers for the following age groups: younger than 30 years, between 30 and 50 years, and older than 50 years.
RESULTS: Of 3,761 patients included in the analysis, 2,153 (57%) were classified as having type 2 TZ, 906 (24%) as type 1 TZ, and 702 (19%) as type 3 TZ. Type 3 TZ was the most commonly reported type in women older than 50 years (70%). We found that the relative distribution of type 3 TZ between age groups was similar in the participating colposcopy clinics. However, there was evidence of heterogeneous distribution of types 1 and 2 TZ between age groups in different clinics, ranging from 7.8% to 66.4% for type 1 TZ in women younger than 30 years and 28.9% to 78.1% for type 2 TZ in women 30 to 50 years old.
CONCLUSIONS: Although IFCPC type 3 TZ seems to be a reproducible finding, the distribution of types 1 and 2 TZ showed significant heterogeneity. A more precise anatomic distinction between types 1 and 2 TZ in the IFCPC terminology could improve reporting of colposcopy findings.

Entities:  

Mesh:

Year:  2015        PMID: 25089552     DOI: 10.1097/LGT.0000000000000069

Source DB:  PubMed          Journal:  J Low Genit Tract Dis        ISSN: 1089-2591            Impact factor:   1.925


  6 in total

1.  Intra and Inter-Observer Variability of Transformation Zone Assessment in Colposcopy: A Qualitative and Quantitative Study.

Authors:  Elizabeth Vallikad; Premalatha Thekkada Siddartha; Kiran Abhijit Kulkarni; Celine Firtion; Payal Keswarpu; Pallavi Vajinepalli; Sarif Naik; Lovi Gupta
Journal:  J Clin Diagn Res       Date:  2017-01-01

2.  Closer to a Uniform Language in Colposcopy: Study on the Potential Application of 2011 International Federation for Cervical Pathology and Colposcopy Terminology in Clinical Practice.

Authors:  Yanyun Li; Xiaoling Duan; Long Sui; Fengying Xu; Shuifang Xu; Hongwei Zhang; Congjian Xu
Journal:  Biomed Res Int       Date:  2017-05-25       Impact factor: 3.411

3.  Diagnostic value of the 2011 International Federation for Cervical Pathology and Colposcopy Terminology in predicting cervical lesions.

Authors:  Aiping Fan; Chen Wang; Liqin Zhang; Ye Yan; Cha Han; Fengxia Xue
Journal:  Oncotarget       Date:  2018-01-08

4.  Performance of colposcopic scoring by modified International Federation of Cervical Pathology and Colposcopy terminology for diagnosing cervical intraepithelial neoplasia in a low-resource setting.

Authors:  Prabhakaran Nair Rema; Aleyamma Mathew; Shaji Thomas
Journal:  South Asian J Cancer       Date:  2019 Oct-Dec

5.  Effect of misoprostol on type 3 transformation zone of the cervix among Cameroonian women.

Authors:  Simon M Manga; Margaret I Liang; Yuanfan Ye; Jeff M Szychowski; Kathleen L Nulah; Alan T Tita; Isabel Scarinci; Warner K Huh
Journal:  Gynecol Oncol Rep       Date:  2022-03-01

6.  Improving colposcopic accuracy for cervical precancer detection: a retrospective multicenter study in China.

Authors:  Bingrui Wei; Bo Zhang; Peng Xue; Samuel Seery; Jiaxu Wang; Qing Li; Yu Jiang; Youlin Qiao
Journal:  BMC Cancer       Date:  2022-04-10       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.